At a glance
ClinicalIndex Comparison RecordN/ACompleted· 416 enrolled
Drug / intervention
Nephrectomyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Incidence of Perioperative Pulmonary Embolism in Patients With Renal Carcinoma Undergoing Nephrectomy
In Brief
An observational study evaluating Nephrectomy for Pulmonary Embolism and 2 related conditions. Completed, enrolled 416 participants across 1 site.
Detailed Summary
Patients with renal carcinoma was reported at high incidence of perioperative pulmonary embolism from current study. The investigators aimed to determine the incidence and outcome of this group of patient in the tertiary-care, university hospital and the rate of intraoperative transesophageal echocardiography utility and outcome.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPulmonary Embolism, Renal Cell Carcinoma, Nephrectomy
CountriesThailand
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedMay 2020
Enrollment StartOct 2020
Primary CompletionSep 2022
Study CompletionDec 2022
TodayJul 2026
First PostedMay 27, 2020
Enrollment StartOct 1, 2020
Primary CompletionSep 30, 2022
Study CompletionDec 30, 2022
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 6.1 years ago
Interventions
Nephrectomyother
Patients underwent nephrectomy